Last update:

Allergy and immunology news

Tezepelumab helps severe asthma patients reduce oral steroids over 28 weeks

New results from the Phase III SUNRISE clinical trial show that tezepelumab significantly reduced the need for long-term oral corticosteroid use in adults with severe oral corticosteroid-dependent asthma while maintaining ...

Blood proteins flag multiple sclerosis years before diagnosis, opening a window for prevention

A new study has revealed a group of blood proteins that are altered in people who go on to develop multiple sclerosis (MS), in some cases more than a decade before diagnosis. The findings offer hope that a simple blood test ...

Elite immune cells lead the fight against multiple myeloma

Immunotherapy for cancer works like a guided missile, directing the body's immune cells toward tumor cells. However, not all immune cells respond to the call to attack, and this can lead to variability in treatment responses. ...